Navigation Links
Study examines association between Parkinson disease, cancer
Date:9/3/2012

CHICAGO A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.

Neurodegenerative diseases, in particular PD, may share common pathogenic mechanisms with some cancers, according to the study background.

"Identifying a genetic relationship between PD and cancer is critical to understanding underlying pathophysiologic changes in both diseases. Understanding this relationship could allow clinicians to provide proper assessment of cancer risk in patients with PD and might also have implications for the counseling of relatives of patients," the authors note in the study background.

Seth A. Kareus, M.D., and colleagues from the University of Utah, Salt Lake City, estimated relative risks (RRs) for cancer in individuals with PD listed on their death certificate, and in their relatives. The study identified 2,998 patients with PD listed as their cause of death from 1904 to 2008 and also included information from the Utah Cancer Registry on 100,817 patients diagnosed with cancer.

To validate their observed associations, researchers also estimated the reciprocal RR for PD death among patients diagnosed with melanoma and their relatives, and estimated the RRs for death with PD among patients diagnosed with prostate cancer and their relatives.

"A significantly increased risk for prostate cancer was observed in the PD population as well as among their relatives. A reciprocal significantly increased risk for PD was also found in the 22,147 prostate cancer cases and their relatives," according to the study results.

The study also notes that "a significantly elevated risk for melanoma was found in the Utah PD population as well as in their relatives. A reciprocal significantly increased relative risk for PD was found in 7,841 Utah melanoma cases and their relatives," the study results indicate.

Among the individuals with PD who died, the authors observed 48 cases of melanoma. The estimated RR for melanoma in patients with PD who died was 1.95; and an increased risk for death with PD was noted among the patients with melanoma (RR, 1.65). Researchers also found prostate cancer in 212 patients with PD who died (RR, 1.71) and an increased risk for death with PD was found among the prostate cancer patients (RR, 1.39), according to the results.

"Thus, these data argue strongly for a significant shared genetic risk for specific cancers on the one hand and neurodegeneration on the other. .These studies provide a framework for future definition of the precise nature of shared genetic variation leading to neurodegeneration in some individuals, but skin or prostate cancers in others, and they may influence strategies for skin and prostate cancer screening," the authors conclude.

(Arch Neurol. Published online September 3, 2012. doi:10.1001/archneurol.2012.2261. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Two authors disclosed grant support, with one author disclosing consulting fees and speaking honoraria. This research was supported by the Utah Cancer Registry, which is funded by a contract from the National Cancer Institute's Surveillance, Epidemiology and End Results program, with additional support from the Utah State Department of Health and the University of Utah. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Families with Parkinson Disease, Cancer

In an editorial, Walter A. Rocca, M.D., M.P.H., of the Mayo Clinic, Rochester, Minn., writes: "The findings from Kareus et al, combined with previous findings in the literature, suggest that some families have a genetic predisposition that can manifest as PD, as other types of parkinsonism, as essential tremor, as cognitive impairment or dementia, as amyotrophic lateral sclerosis, as anxiety disorders, as depressive disorders, or as nonneurological conditions such as melanoma and prostate cancer."

"If the mechanisms are primarily genetic, as suggested by Kareus and colleagues, then it may be possible to identify genetic variants that predispose to accelerated neurodegeneration and to increased oncogenesis in the same individual or among members of some particular families," Rocca continues.

"On the other hand, if PD is multifactorial at the individual level, dimorphic in men and women, and heterogeneous at the population level, the search for one or several genetic variants may not be productive," Rocca concludes.

(Arch Neurol. Published online September 3, 2012. doi:10.1001/archneurol.2012.2664. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.


'/>"/>
Contact: Kathy Wilets
kathy.wilets@hsc.utah.edu
801-581-5717
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Mathematics or memory? Stanford study charts collision course in brain
2. Few Doctors Discuss Exercise With Cancer Patients: Study
3. Study explores why children with asthma are more likely to be bullied
4. Marathons Safe for Aging Boomers, Study Finds
5. Womens Brains React Differently Than Mens to Alcoholism, Study Finds
6. Smoking After Stroke Triples Risk of Death Within Year: Study
7. Study looks at efforts to improve local food systems through policy
8. Keeping Up a Healthy Lifestyle Pays Off in Added Years: Study
9. Hookah Effects as Harmful as Cigarettes, Study Finds
10. BUSM researchers study use of MRI in osteoarthritis
11. Survival More Likely With Exercise-Related Cardiac Arrest: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , ... February 20, 2017 , ... ... check-in, a cloud-based self-service technology that runs on the Posiflex XT-series of touch ... 1076 during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... Tampa, FL (PRWEB) , ... February 20, 2017 ... ... $20,000 gift from Constellation Brands to purchase a new ultrasound-enhanced thrombolysis machine, a ... ultrasonic waves. The gift was facilitated by the Pepin Family Foundation. , “We ...
(Date:2/19/2017)... ... 2017 , ... Orbita, Inc., a leading provider ... Healthwise ® at HIMSS 2017 to showcase a breakthrough in remote ... technology and services, will demonstrate a voice-powered knowedge assistant based on Orbita ...
(Date:2/18/2017)... ... , ... Park Cities Pet Sitter President, Joette White, has been featured on ... The episode, which was posted this week, features a 30-minute interview of White ... Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... ORLANDO, Fla. , Feb. 20, 2017   ... will migrate its Amadeus precision medicine platform ... Health,s software currently manages over 110 million patient records ... approach to developing cloud-based, big data solutions built on ... Director of Healthcare and Life Sciences. "The AWS Cloud ...
(Date:2/20/2017)... Research and Markets has announced the addition of the ... report to their offering. ... An increasing number of patients suffering ... tension free repair procedures and increasing demand for minimally invasive ... market. However, Inconsistent reimbursement and the high cost of hernia ...
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
Breaking Medicine Technology: